Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Haseeb Nisar, Bilal Wajid, Faria Anwar, Ashfaq Ahmad, Anum Javaid, Syed Awais Attique, Wardah Nisar, Amir Saeed, Samiah Shahid & Saima Sadaf. (2023) Bioinformatics and systems biology analysis revealed PMID26394986-Compound-10 as potential repurposable drug against covid-19. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Read now
Mariana Verdan, Igor Taveira, Flávia Lima, Fernanda Abreu & Dirlei Nico. (2023) Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022). Expert Opinion on Therapeutic Patents 33:3, pages 137-150.
Read now
Read now
Jaya Chakravarty & Shyam Sundar. (2019) Current and emerging medications for the treatment of leishmaniasis. Expert Opinion on Pharmacotherapy 20:10, pages 1251-1265.
Read now
Read now
Natascia Bruni, Barbara Stella, Leonardo Giraudo, Carlo Della Pepa, Daniela Gastaldi & Franco Dosio. (2017) Nanostructured delivery systems with improved leishmanicidal activity: a critical review. International Journal of Nanomedicine 12, pages 5289-5311.
Read now
Read now
Huifeng Zhou, Shuyun Bi, Yu Wang & Jun Wu. (2017) Characterization of the binding of neomycin/paromomycin sulfate with DNA using acridine orange as fluorescence probe and molecular docking technique. Journal of Biomolecular Structure and Dynamics 35:10, pages 2077-2089.
Read now
Read now
Viroj Wiwanitkit. (2012) Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar). Therapeutics and Clinical Risk Management 8, pages 323-328.
Read now
Read now
José Angelo Lauletta Lindoso, Jackson Maurício Lopes Costa, Igor Thiago Queiroz & Hiro Goto. (2012) Review of the current treatments for leishmaniases. Research and Reports in Tropical Medicine 3, pages 69-77.
Read now
Read now
Guilherme Carneiro, Marta Gontijo Aguiar, Ana Paula Fernandes & Lucas Antônio Miranda Ferreira. (2012)
Drug delivery systems for the topical treatment of cutaneous leishmaniasis
. Expert Opinion on Drug Delivery 9:9, pages 1083-1097.
Read now
Read now
Smriti Mondal, Pradyot Bhattacharya & Nahid Ali. (2010) Current diagnosis and treatment of visceral leishmaniasis. Expert Review of Anti-infective Therapy 8:8, pages 919-944.
Read now
Read now
Sheila J Thornton & Kishor M Wasan. (2009) The reformulation of Amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis. Expert Opinion on Drug Delivery 6:3, pages 271-284.
Read now
Read now
Articles from other publishers (67)
Fernando A.P. de Sá, Jayanaraian F.M. Andrade, Thamires C. Miranda, Marcilio Cunha-Filho, Guilherme M. Gelfuso, Maria Lapteva, Yogeshvar N. Kalia & Taís Gratieri. (2023) Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches. International Journal of Pharmaceutics 648, pages 123617.
Crossref
Crossref
Vrushali Guhe, Prajakta Ingale, Anil Tambekar & Shailza Singh. (2023) Systems biology of autophagy in leishmanial infection and its diverse role in precision medicine. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Juliana Figueiredo Peixoto, Luiz Filipe Gonçalves-Oliveira, Franklin Souza-Silva, Luzia Monteiro de Castro Côrtes, Geovane Dias-Lopes, Flávia de Oliveira Cardoso, Rafael de Oliveira Santos, Beatriz Ferreira de Carvalho Patricio, Caroline Deckmann Nicoletti, Carolina Guimarães de Souza Lima, Kátia da Silva Calabrese, Davyson de Lima Moreira, Helvécio Vinícius Antunes Rocha, Fernando de Carvalho da Silva, Vitor Francisco Ferreira & Carlos Roberto Alves. (2023) Development of a microemulsion loaded with epoxy-α-lapachone against Leishmania (Leishmania) amazonensis murine infection. International Journal of Pharmaceutics 636, pages 122864.
Crossref
Crossref
Muhammad Adil, Pragya Tiwari, Mavara Iqbal, Shamsa Kanwal & Aisha Umar. 2023. Pharmacological Benefits of Natural Agents. Pharmacological Benefits of Natural Agents
225
249
.
Fauzia Jamal, Ishrat Altaf, Ghufran Ahmed, Sheikh Asad, Hira Ahmad, Qamar Zia, Asim Azhar, Saba Farheen, Taj Shafi, Shabana Karim, Swaleha Zubair & Mohammad Owais. (2023) Amphotericin B Nano-Assemblies Circumvent Intrinsic Toxicity and Ensure Superior Protection in Experimental Visceral Leishmaniasis with Feeble Toxic Manifestation. Vaccines 11:1, pages 100.
Crossref
Crossref
V. Kumar, Maxima Madhu & Krishna Murti. 2023. Viral, Parasitic, Bacterial, and Fungal Infections. Viral, Parasitic, Bacterial, and Fungal Infections
389
406
.
Yash Gupta, Steven Goicoechea, Jesse Vance, Andres P. Trujillo, Akankcha Alok, Samuel K. Kwofie, Brijesh Rathi, Ravi Durvasula & Prakasha Kempaiah. 2023. Natural Product Based Drug Discovery Against Human Parasites. Natural Product Based Drug Discovery Against Human Parasites
329
383
.
Shabi Parvez, Archana Karole, Yirivinti Hayagreeva Dinakar & Shyam Lal Mudavath. (2022) Nanoformulation mediated silencing of P-gp efflux protein for the efficient oral delivery of anti-leishmanial drugs. Journal of Drug Delivery Science and Technology 78, pages 103959.
Crossref
Crossref
Sushmita Ghosh, Vinay Kumar, Aditya Verma, Tanya Sharma, Dibyabhaba Pradhan, Angamuthu Selvapandiyan, Poonam Salotra & Ruchi Singh. (2022) Genome-wide analysis reveals allelic variation and chromosome copy number variation in paromomycin-resistant Leishmania donovani. Parasitology Research 121:11, pages 3121-3132.
Crossref
Crossref
Ignace C. Roseboom, Bas Thijssen, Hilde Rosing, Fabiana Alves, Brima M. Younis, Ahmed M. Musa, Jos H. Beijnen & Thomas P.C. Dorlo. (2022) Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissue. Journal of Chromatography B, pages 123494.
Crossref
Crossref
Gert-Jan Wijnant, Franck Dumetz, Laura Dirkx, Dimitri Bulté, Bart Cuypers, Katrien Van Bocxlaer & Sarah Hendrickx. (2022) Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Frontiers in Tropical Diseases 3.
Crossref
Crossref
Carlos F. M. Silva, Diana C. G. A. Pinto, Pedro A. Fernandes & Artur M. S. Silva. (2022) Evolution of Acridines and Xanthenes as a Core Structure for the Development of Antileishmanial Agents. Pharmaceuticals 15:2, pages 148.
Crossref
Crossref
Juan Güiza, Javiera Arriagada, Luis Rodríguez, Camila Gutiérrez, Yorley Duarte, Juan C. Sáez & José L. Vega. (2021) Anti-parasitic drugs modulate the non-selective channels formed by connexins or pannexins. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1867:10, pages 166188.
Crossref
Crossref
Patrick O. Sakyi, Richard K. Amewu, Robert N. O. A. Devine, Emahi Ismaila, Whelton A. Miller & Samuel K. Kwofie. (2021) The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade. Natural Products and Bioprospecting 11:5, pages 489-544.
Crossref
Crossref
Jared T. Hammill, Vitaliy M. Sviripa, Liliia M. Kril, Diana Ortiz, Corinne M. Fargo, Ho Shin Kim, Yizhe Chen, Jonah Rector, Amy L. Rice, Malgorzata A. Domagalska, Kristin L. Begley, Chunming Liu, Vivek M. Rangnekar, Jean-Claude Dujardin, David S. Watt, Scott M. Landfear & R. Kiplin Guy. (2021) Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents. Journal of Medicinal Chemistry 64:16, pages 12152-12162.
Crossref
Crossref
Simone SC Oliveira, Carine S Ferreira, Marta H Branquinha, André LS Santos, Marco V Chaud, Sona Jain, Juliana C Cardoso, Anđelka B Kovačević, Eliana B Souto & Patrícia Severino. (2020) Overcoming multi‐resistant leishmania treatment by nanoencapsulation of potent antimicrobials. Journal of Chemical Technology & Biotechnology 96:8, pages 2123-2140.
Crossref
Crossref
Rodrigo Ochoa, Amaya Ortega-Pajares, Florencia A. Castello, Federico Serral, Darío Fernández Do Porto, Janny A. Villa-Pulgarin, Rubén E. Varela-M & Carlos Muskus. (2021) Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species. Biomolecules 11:7, pages 1037.
Crossref
Crossref
Sriram Kannan, Yifat Harel, Esthy Levy, Avishay Dolitzky, Assaf E. Sagiv, Saurav Aryal, Laila Suleman, Jean-Paul Lellouche & Shulamit Michaeli. (2021) Nano-Leish-IL: A novel iron oxide-based nanocomposite drug platform for effective treatment of cutaneous leishmaniasis. Journal of Controlled Release 335, pages 203-215.
Crossref
Crossref
Ashutosh Paliwal, Rekha Gahtori, Amrita Kumari & Pooja Pandey. 2021. Pathogenesis, Treatment and Prevention of Leishmaniasis. Pathogenesis, Treatment and Prevention of Leishmaniasis
103
124
.
Jiří Pospíšil, Daniela Konrádová & Miroslav Strnad. 2021. Progress in the Chemistry of Organic Natural Products 115. Progress in the Chemistry of Organic Natural Products 115
115
176
.
Douglas O. Escrivani, Gabriela C. Mattos, Bartira Rossi-Bergmann & Ariane J. Sousa-Batista. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
181
217
.
Awais Ahmad, N.M Mubarak, Khalida Naseem, Hina Tabassum, Muhammad Rizwan, Agnieszka Najda, M. Kashif, May Bin-Jumah, Afzal Hussain, Asma Shaheen, Mohamed M. Abdel-Daim, Shafaqat Ali & Shahid Hussain. (2020) Recent advancement and development of chitin and chitosan-based nanocomposite for drug delivery: Critical approach to clinical research. Arabian Journal of Chemistry 13:12, pages 8935-8964.
Crossref
Crossref
Michel Muálem de Moraes Alves, Daniel Dias Rufino Arcanjo, Kayo Alves Figueiredo, Jéssica Sara de Sousa Macêdo Oliveira, Felipe José Costa Viana, Elvilene de Sousa Coelho, Glaucia Lais Nunes Lopes, Juan Carlos Ramos Gonçalves, André Luís Menezes Carvalho, Márcia dos Santos Rizzo, Mariana Helena Chaves, Ivete Lopes de Mendonça & Fernando Aécio de Amorim Carvalho. (2020) Gallic and Ellagic Acids Are Promising Adjuvants to Conventional Amphotericin B for the Treatment of Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy 64:12.
Crossref
Crossref
Bruno Mendes Roatt, Jamille Mirelle de Oliveira Cardoso, Rory Cristiane Fortes De Brito, Wendel Coura-Vital, Rodrigo Dian de Oliveira Aguiar-Soares & Alexandre Barbosa Reis. (2020) Recent advances and new strategies on leishmaniasis treatment. Applied Microbiology and Biotechnology 104:21, pages 8965-8977.
Crossref
Crossref
Eduardo Seiji Yamamoto, Jéssica Adriana de Jesus, Adriana Bezerra-Souza, Juliana R. Brito, João Henrique G. Lago, Márcia Dalastra Laurenti & Luiz Felipe Domingues Passero. (2020) Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp.. Bioorganic Chemistry 102, pages 104056.
Crossref
Crossref
Mariona Pinart, José-Ramón Rueda, Gustavo AS Romero, Carlos Eduardo Pinzón-Flórez, Karime Osorio-Arango, Ana Nilce Silveira Maia-Elkhoury, Ludovic Reveiz, Vanessa M Elias & John A Tweed. (2020) Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Crossref
A.P.S. Matos, A.L. Viçosa, M.I. Ré, E. Ricci-Júnior & C. Holandino. (2020) A review of current treatments strategies based on paromomycin for leishmaniasis. Journal of Drug Delivery Science and Technology 57, pages 101664.
Crossref
Crossref
Anindita Paul & Sushma Singh. 2020. Metagenomic Systems Biology. Metagenomic Systems Biology
75
93
.
F. Esfandiari, M.H. Motazedian, Q. Asgari, M.H. Morowvat, M. Molaei & H. Heli. (2019) Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis. Acta Tropica 197, pages 105072.
Crossref
Crossref
F. Esfandiari, M.H. Motazedian, Q. Asgari, M.H. Morowvat, M. Molaei & H. Heli. (2019) Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis. Acta Tropica 197, pages 105045.
Crossref
Crossref
Iqra Afzal, Hafiz Shoaib Sarwar, Muhammad Farhan Sohail, Sanjay Varikuti, Sarwat Jahan, Sohail Akhtar, Masoom Yasinzai, Abhay R Satoskar & Gul Shahnaz. (2019) Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis. Nanomedicine 14:4, pages 387-406.
Crossref
Crossref
Neeraj Tiwari, Arun Kumar, Ashish K. Singh, Surabhi Bajpai, Anand K. Agrahari, Dhiraj Kishore, Vinod K. Tiwari & Rakesh K. Singh. 2019. Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases. Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases
293
350
.
Alessandra Almeida Filardy, Kamila Guimarães-Pinto, Marise Pinheiro Nunes, Ketiuce Zukeram, Lara Fliess, Ludimila Pereira, Danielle Oliveira Nascimento, Luciana Conde & Alexandre Morrot. (2018) Human Kinetoplastid Protozoan Infections: Where Are We Going Next?. Frontiers in Immunology 9.
Crossref
Crossref
C. Benjamin Naman, Ciro M. Gomes & Gaurav Gupta. 2018. Natural Products and Drug Discovery. Natural Products and Drug Discovery
213
275
.
Muhammad Ovais, Akhtar Nadhman, Ali Talha Khalil, Abida Raza, Fazli Khuda, Muhammad Farhan Sohail, Nazar Ul Islam, Hafiz Shoaib Sarwar, Gul Shahnaz, Irshad Ahmad, Muthupandian Saravanan & Zabta Khan Shinwari. (2017) Biosynthesized colloidal silver and gold nanoparticles as emerging leishmanicidal agents: an insight. Nanomedicine 12:24, pages 2807-2819.
Crossref
Crossref
Luiz Filipe Gonçalves de Oliveira, Bernardo Acácio Santini Pereira, Benjamin Gilbert, Arthur Luiz Corrêa, Leandro Rocha & Carlos Roberto Alves. (2016) Natural products and phytotherapy: an innovative perspective in leishmaniasis treatment. Phytochemistry Reviews 16:2, pages 219-233.
Crossref
Crossref
Swati Pund & Amita Joshi. 2017. Nano- and Microscale Drug Delivery Systems. Nano- and Microscale Drug Delivery Systems
439
480
.
Shyam Sundar & Jaya Chakravarty. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1293
1304
.
Om Prakash Singh, Bhawana Singh, Jaya Chakravarty & Shyam Sundar. (2016) Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective. Infectious Diseases of Poverty 5:1.
Crossref
Crossref
Vineetha Mandlik, Sohan Patil, Ramanamurthy Bopanna, Sudipta Basu & Shailza Singh. (2016) Biological Activity of Coumarin Derivatives as Anti-Leishmanial Agents. PLOS ONE 11:10, pages e0164585.
Crossref
Crossref
Eglal I. Amer, Maha M. Eissa & Shereen F. Mossallam. (2014) Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis. Journal of Parasitic Diseases 40:2, pages 475-484.
Crossref
Crossref
Hamid Iqbal, Muhammad Ishfaq, Abdul Wahab, Muhammad Naseer Abbas, Ijaz Ahmad, Ali Rehman & Muhammad Zakir. (2016) Therapeutic modalities to combat leishmaniasis, a review. Asian Pacific Journal of Tropical Disease 6:1, pages 1-5.
Crossref
Crossref
Mohammad Asad, Pradyot Bhattacharya, Antara Banerjee & Nahid Ali. (2015) Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B. BMC Infectious Diseases 15:1.
Crossref
Crossref
Anita Masic, Ana Maria Valencia Hernandez, Sudipta Hazra, Jan Glaser, Ulrike Holzgrabe, Banasri Hazra & Uta Schurigt. (2015) Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice. PLOS ONE 10:11, pages e0142386.
Crossref
Crossref
Maria Manuela Gaspar, Susana Calado, Joana Pereira, Helena Ferronha, Ivone Correia, Helena Castro, Ana M. Tomás & Maria Eugénia Meirinhos Cruz. (2015) Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems. Nanomedicine: Nanotechnology, Biology and Medicine 11:7, pages 1851-1860.
Crossref
Crossref
Jaiprakash N. Sangshetti, Firoz A. Kalam Khan, Abhishek A. Kulkarni, Rohidas Arote & Rajendra H. Patil. (2015) Antileishmanial drug discovery: comprehensive review of the last 10 years. RSC Advances 5:41, pages 32376-32415.
Crossref
Crossref
Stephen Hanessian, Oscar M. Saavedra, Miguel A. Vilchis-Reyes & Ana M. Llaguno-Rueda. (2014)
Synthesis of 4′-deoxy-4′-fluoro neamine and 4′-deoxy-4′-fluoro 4′-
epi
neamine
. MedChemComm 5:8, pages 1166-1171.
Crossref
Crossref
Nisha Singh, Bhuwan B. Mishra, Surabhi Bajpai, Rakesh K. Singh & Vinod K. Tiwari. (2014) Natural product based leads to fight against leishmaniasis. Bioorganic & Medicinal Chemistry 22:1, pages 18-45.
Crossref
Crossref
Heena Sachdeva, Rakesh Sehgal & Sukhbir Kaur. (2013) Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis. Parasitology Research 112:6, pages 2269-2280.
Crossref
Crossref
Jiro Kondo, Mai Koganei, Juan Pablo Maianti, Vu Linh Ly & Stephen Hanessian. (2013) Crystal Structures of a Bioactive 6′‐Hydroxy Variant of Sisomicin Bound to the Bacterial and Protozoal Ribosomal Decoding Sites. ChemMedChem 8:5, pages 733-739.
Crossref
Crossref
Bhuwan B. Mishra, Navneet Kishore, Rakesh K. Singh & Vinod Kumar Tiwari. 2013. Natural Products. Natural Products
1263
1299
.
Johan van Griensven & Ermias Diro. (2012) Visceral Leishmaniasis. Infectious Disease Clinics of North America 26:2, pages 309-322.
Crossref
Crossref
Sarah Hendrickx, Raquel Andrea Inocêncio da Luz, Vasundhra Bhandari, Kristel Kuypers, Craig D. Shaw, Julien Lonchamp, Poonam Salotra, Katharine Carter, Shyam Sundar, Suman Rijal, Jean-Claude Dujardin, Paul Cos & Louis Maes. (2012) Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol. PLoS Neglected Tropical Diseases 6:5, pages e1664.
Crossref
Crossref
Hamid Daneshvar, Susan Wyllie, Stephen Phillips, Paul Hagan & Richard Burchmore. (2012) Comparative proteomics profiling of a gentamicin-attenuated Leishmania infantum cell line identifies key changes in parasite thiol-redox metabolism. Journal of Proteomics 75:5, pages 1463-1471.
Crossref
Crossref
Luis Carvalho, Juan Román Luque-Ortega, Carmen López-Martín, Santiago Castanys, Luis Rivas & Francisco Gamarro. (2011) The 8-Aminoquinoline Analogue Sitamaquine Causes Oxidative Stress in Leishmania donovani Promastigotes by Targeting Succinate Dehydrogenase. Antimicrobial Agents and Chemotherapy 55:9, pages 4204-4210.
Crossref
Crossref
Arpita Kulshrestha, Ruchi Singh, Dhiraj Kumar, Narender Singh Negi & Poonam Salotra. (2011) Antimony-Resistant Clinical Isolates of Leishmania donovani Are Susceptible to Paromomycin and Sitamaquine. Antimicrobial Agents and Chemotherapy 55:6, pages 2916-2921.
Crossref
Crossref
Antara Banerjee, Manjarika De & Nahid Ali. (2011) Combination Therapy with Paromomycin-Associated Stearylamine-Bearing Liposomes Cures Experimental Visceral Leishmaniasis through Th1-Biased Immunomodulation. Antimicrobial Agents and Chemotherapy 55:4, pages 1661-1670.
Crossref
Crossref
Juan R. Luque-OrtegaLuis J. CruzFernando AlbericioLuis Rivas. (2010) The Antitumoral Depsipeptide IB-01212 Kills Leishmania through an Apoptosis-like Process Involving Intracellular Targets. Molecular Pharmaceutics 7:5, pages 1608-1617.
Crossref
Crossref
Jean-Claude Dujardin, Dolores González-Pacanowska, Simon L. Croft, Ole F. Olesen & Gerald F. Späth. (2010) Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas. Trends in Parasitology 26:8, pages 395-403.
Crossref
Crossref
Smriti Mondal, Pradyot Bhattacharya, Mehebubar Rahaman, Nahid Ali & Rama Prosad Goswami. (2010) A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy. PLoS Neglected Tropical Diseases 4:7, pages e764.
Crossref
Crossref
Jorge Alvar, Urbà González, Mariona Pinart, Soumik Kalita, Mercè Herrero, Ivan D Vélez & Shyam Sundar. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Johan van Griensven, Manica Balasegaram, Filip Meheus, Jorge Alvar, Lutgarde Lynen & Marleen Boelaert. (2010) Combination therapy for visceral leishmaniasis. The Lancet Infectious Diseases 10:3, pages 184-194.
Crossref
Crossref
Alicia Ponte-Sucre, Tanja Gulder, Tobias A. M. Gulder, Gerina Vollmers, Gerhard Bringmann & Heidrun Moll. (2010) Alterations to the structure of Leishmania major induced by N-arylisoquinolines correlate with compound accumulation and disposition. Journal of Medical Microbiology 59:1, pages 69-75.
Crossref
Crossref
Varvara Pokrovskaya, Igor Nudelman, Jeyakumar Kandasamy & Timor Baasov. 2010. Glycomics. Glycomics
437
462
.
L. Ordóñez-Gutiérrez, M. Martínez, I. Rubio-Somoza, I. Díaz, S. Mendez & J.M. Alunda. (2009) Leishmania infantum: Antiproliferative effect of recombinant plant cystatins on promastigotes and intracellular amastigotes estimated by direct counting and real-time PCR. Experimental Parasitology 123:4, pages 341-346.
Crossref
Crossref
Néstor M. Carballeira, Michelle M. Cartagena, Christopher Fernández Prada, Celia Fernández Rubio & Rafael Balaña‐Fouce. (2009) Total Synthesis and Antileishmanial Activity of the Natural Occurring Acetylenic Fatty Acids 6‐Heptadecynoic Acid and 6‐Icosynoic Acid. Lipids 44:10, pages 953.
Crossref
Crossref
Robert Bergquist. (2009) Parasitic infections affecting the oral cavity. Periodontology 2000 49:1, pages 96-105.
Crossref
Crossref